## LII: Lennox International Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 1.51 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (50% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($475.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stake in AbbVie Inc. $ABBV**
- Source: MarketBeat | 20251231T115821 | Neutral | Relevance: 63%
- VIRGINIA RETIREMENT SYSTEMS ET Al increased its holdings in AbbVie Inc. by 48.9% in the third quarter, acquiring 96,200 additional shares to reach a total of 293,111 shares valued at $67.9 million. This move comes as AbbVie reported strong Q3 earnings, beating analyst estimates with $1.86 EPS and $15.78 billion in revenue, prompting an increase in its quarterly dividend to $1.73. Institutional ownership of AbbVie stands at 70.23%, with major firms like Vanguard and Geode Capital Management also increasing their positions, and analysts maintaining a "Moderate Buy" consensus with a $245.84 target price.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Barclays | $680 | $700 | -3% |
| 2025-12-04 | Wells Fargo | $525 | $545 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Barclays | main | Overweight |
| 2025-12-04 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.19M) |
| Sells | 8 ($2.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 8.6% (+0.7%)
- Capital Internationa: 4.2% (-4.7%)
- State Street Corpora: 4.1% (+2.3%)
- Morgan Stanley: 3.8% (-5.6%)

### Key Risks

1. Long-term trend broken: trading 9.1% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +1.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.51 elevated, pricing in significant growth expectations. Forward P/E 20.2x stretched relative to 8% growth. Quality metrics strong (ROE 92%, ROA 19%, margin 16%). Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($2.4M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.5B |
| Beta | 1.16 |
| 52W Range | $443.19 - $689.44 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.51 |
| Forward P/E | 20.2 |
| Current P/E | 21.8 |
| YoY Growth | 7.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.1% to 0.9% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 at 1.7% confirms short-term momentum alignment. Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 53. Volume at 50% of 20MA suggests lack of conviction. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.86% (CS: 52) | Neutral |
| RSI_14 | 52.6 | Neutral |
| MACD Histogram | -0.48 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 0.909x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $498.91
- **Stop Loss:** $475.31 (4.7% risk)
- **Target:** $522.51 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 61
- **Position Value:** $30,433.51
- **Portfolio %:** 30.43%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $4.76)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.84 | $6.98 | +2.0% |
| 2025Q2 | $6.87 | $7.82 | +13.9% |
| 2025Q1 | $3.25 | $3.37 | +3.6% |
| 2024Q4 | $4.24 | $5.60 | +32.0% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*